Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06CSK
|
|||
| Former ID |
DIB008750
|
|||
| Drug Name |
BCT-194
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 1 | [1] | |
| Company |
Novartis AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01539915) Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.